RCS - Kanabo Group PLC - Contract Extension

KanaboAnnouncement

09/06/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220609:nRSI2925Oa&default-theme=true

RNS Number : 2925O  Kanabo Group PLC  09 June 2022

 

Kanabo Group Plc.

("Kanabo" or the "Company")

 

Contract Extension

 

The GP Service Extends its Contact with a Major UK Food Retailer

 

Kanabo Group Plc. (LON: KNB), announces an extension to its existing contract
between the GP Service and one of the United Kingdom's ("UK") largest group of
retail businesses including food retail, wholesale, e-pharmacy, insurance, and
legal services.

 

The recently acquired GP Service, originally partnered with the retailer in
2019, for the provision of general medical assistance for its members.  The
original agreement was limited to the submission of the patient's medical
history online where the GP Service doctors would review information provided
by the patient and complete the prescription for the retailer to arrange
subsequent fulfilment and delivery of any approved medication.

 

Under the new Contract Extension, the GP Service will also now provide live
Video Consultation services with prescriptions available for collection
through the GP Service partner network of over 4,000 pharmacies across the UK.
Users will normally see a doctor and may receive a prescription for collection
on the same video call. In addition to prescription services, the GP Service
will also provide fit notes and referrals.

 

Consultations will be available between 8am and 8pm, Monday to Sunday, 365
days a year. Consultations are usually available within 30 minutes with
approximately 95% of all prescriptions available within 60 minutes of the
consultation.

 

Atul Devani, CEO of the GP Service commented: "The extension of this agreement
reflects the successful relationship we have had since we began working
together in 2019. Our integration with the NHS summary care records ensures
our services are both safe & secure and we now look forward to extending
our services to include virtual GP consultations with automated digital
prescriptions."

 

Kanabo, CEO, Avihu Tamir, said: "I am delighted to see this contract extension
with a major retailer in the UK, which goes a long way to validating our
rationale for the acquisition earlier this year. The GP Service is an
innovative Telemedicine Provider, that forms an integral part of the overall
strategy at Kanabo, and I look forward to extending our services in the UK
further over the coming months and years."

 

 

For further information, please visit http://www.kanabogroup.com/ or
https://www.voxmarkets.co.uk/listings/LON/KNB
(https://www.voxmarkets.co.uk/listings/LON/KNB) or contact the following:

 

 Kanabo Group Plc                            Via Vox Markets
 Avihu Tamir, CEO
 Peterhouse Capital Ltd (Financial Adviser)  Tel: +44 (0)20 7469 0930
 Eran Zucker / Lauren Riley
 Vox Markets (Investor Relations)            KanaboGroup@voxmarkets.co.uk
 Kat Perez                                   kperez@voxmarkets.co.uk

 

 

 

About Kanabo Group Plc

Kanabo Group Plc is creating a new standard in the medical cannabis industry
to improve the well-being of millions of people around the world by providing
a better alternative to the smoking of medicinal cannabis flowers. Kanabo,
which was the first medicinal cannabis company to IPO on London Stock
Exchange, has a focus on the distribution of cannabis-derived products for
medical patients and non-THC products for CBD consumers.

 

It has conducted extensive Research & Development to produce high-quality
cannabis extract formulas, innovative medical-grade vaporizers, and various
non-smoking consumption solutions. Kanabo sells a range of medical cannabis
products and wellness CBD products in the Primary Markets, including its
VapePod, which delivers a metered dose with every inhalation.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAFIFEERDIAIIF